Skip to main content
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.270
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.390
+0.120 (2.80%)
After-hours: Dec 5, 2025, 7:18 PM EST

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had revenue of $15.65M in the twelve months ending September 30, 2025. In the fiscal year ending June 30, 2025, Neuphoria Therapeutics had annual revenue of $15.65M.

Revenue (ttm)
$15.65M
Revenue Growth
n/a
P/S Ratio
0.51
Revenue / Employee
$1,956,181
Employees
8
Market Cap
22.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202515.65M--
Jun 30, 2024---
Jun 30, 2023---
Jun 30, 20224.17M3.48M499.60%
Jun 30, 2021695.81K-1.37M-66.32%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

NEUP News

More News